Prof. Bernardo Sanchez

Strengthening the finance, operations, manufacturing, and controlling functions. Reporting to the global performance director, coordinating with Germany-based executive leaders. Leading five shared service team members, managing supply chains across the EMEA and Turkey regions, and cultivating partnerships with third-party logistics companies across Spain, Portugal, Italy, Germany, and the UK. Administer and develop internal controls to ensure compliance with IFRS, HGB, and SOX standards

Opinion on manufacturing plant consolidation; proposal on strategic steering concept; opinion on consolidation of two central distribution warehouses (CDC) including a proposal improve transfer pricing, to lower operational complexity at affiliate levels, proposal to set new challenges at affiliate levels, including a new P&L to improve transparency on the cost of goods sold and manufacturing, as part of the consolidation process

a) Split operations model into three independent Businesses: Net revenues: 900 m euros. b) Implemented transformation plan,increased Gross Profit Margin,: 20m euros c) Led site consolidation and capacity increase on production from 3,6m to 9,2m syringes, revenues 670 m (9,5% cagr), EBITDA 330m (15% cagr) d) Control on manufacturing sites globally (Europe and USA) with a direct influence of 154,3m

Optimized a €50 million annual cash flow and €28 million turnover, analyzed DSO/DPO cycles, and maintained disciplined financial management and zero debt from intercompany and third-party sources. Led a team of 12 people, conducted sales and operations planning (S&OP) reviews, and improved tax rates and inventory management.

Spearheaded the financial stewardship for three manufacturing sites with 60 scientists, led a team of 15 people, managed SAP implementation, and improved operational efficiency and financial reporting functions. Oversaw $100 million in manufacturing costs (this contributed to Apotex Group’s annual turnover of $1.2 billion, which accounts for 60% out of the total) and a global export network spanning 150+ countries and operating structures between India, Asia, Mexico, NA, and the rest of the world.

Oversaw the entire accounting lifecycle and standardized budget and regulatory controls across three businesses to ensure compliance. Managed €21.1 million budget, forecasted projections, and cash flows to maximize gross profits. Refined S&OP product demand reviews and attained 80% forecast accuracy. Managed a team of 12 people and reported to the CFO of Latin America.